Business

Precipio Reschedules Q2-2021 Shareholder Update Call

Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM EST NEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer

articlePrecipio, Inc.August 20, 20215/company/precipio-inc/news/precipio-reschedules-q2-2021-shareholder-update-call
Precipio Reschedules Q2-2021 Shareholder Update Call

About this update from Precipio, Inc.

[{"type":"text","content":"Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM EST\nNEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to Thursday, August 26th at 5:00 PM ET due to a schedule conflict. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call to https://dpregister.com/sreg/10159643/ec749304c3 and will receive a calendar invite and a direct dial-in number, bypassing the operator. Listeners interested in submitting questions in advance should email their questions to [email protected] and management will do its best to address those questions during the call. A replay of the call will be available approximately 24 hours after the call and may be accessed via the Investors page on Precipio's website, http://www.precipiodx.com/investors.html. About Precipio Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard’s Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com. Please follow us on Twitter @PrecipioDx and on Facebook. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of operations, and a...

More updates from Precipio, Inc.